Interstitial pneumonitis after treatment with bevacizumab and pegylated liposomal doxorubicin in a patient with metastatic breast cancer

MeSH terms

• Antibodies, Monoclonal / adverse effects*
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Bevacizumab
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / pathology
• Doxorubicin / analogs & derivatives*
• Doxorubicin / therapeutic use
• Female
• Humans
• Lung Diseases, Interstitial / etiology*
• Middle Aged
• Polyethylene Glycols / therapeutic use*
• Respiratory Function Tests
• Stomach Neoplasms / secondary
• Tomography, X-Ray Computed